SCM
ABMD

Sterling Capital Management’s Abiomed Inc ABMD Stock Holding History

Sterling Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,139
Closed -$2.21M – 981
2017
Q3 		$2.21M Buy
13,139
+281
+2% +$42.5K 0.02% 388
2017
Q2 		$1.84M Hold
12,858
– – 0.02% 406
2017
Q1 		$1.61M Buy
12,858
+1,351
+12% +$157K 0.02% 440
2016
Q4 		$1.3M Buy
11,507
+688
+6% +$79.7K 0.01% 492
2016
Q3 		$1.39M Sell
10,819
-2,106
-16% -$252K 0.01% 459
2016
Q2 		$1.41M Sell
12,925
-4,440
-26% -$442K 0.01% 460
2016
Q1 		$1.65M Buy
17,365
+1,621
+10% +$137K 0.02% 421
2015
Q4 		$1.42M Buy
15,744
+3,606
+30% +$306K 0.01% 452
2015
Q3 		$1.13M Sell
12,138
-15,340
-56% -$1.35M 0.01% 507
2015
Q2 		$1.81M Sell
27,478
-12,789
-32% -$850K 0.02% 312
2015
Q1 		$2.88M Buy
40,267
+716
+2% +$38.9K 0.03% 253
2014
Q4 		$1.5M Buy
39,551
+764
+2% +$24.1K 0.01% 530
2014
Q3 		$963K Buy
38,787
+27,760
+252% +$703K 0.01% 624
2014
Q2 		$277K Buy
+11,027
New +$257K ﹤0.01% 819

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sterling Capital Management's ABMD Position: Q4 2017 in Review

Sterling Capital Management sold out of Abiomed Inc (ABMD) in Q4 2017, closing a stake of 13,139 shares — an estimated $2.21M sold.

Sterling Capital Management first reported a position in ABMD in Q2 2014 and held it in 14 quarters. The position peaked at $2.88M in Q1 2015. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Sterling Capital Management reported no remaining Abiomed Inc position as of Q4 2017 after selling out during the quarter.
  • Sterling Capital Management sold 13,139 Abiomed Inc shares in Q4 2017, an estimated $2.21M.
  • Sterling Capital Management first reported a position in Abiomed Inc in Q2 2014 and held it in 14 quarters.
  • Sterling Capital Management's Abiomed Inc position peaked at $2.88M in Q1 2015.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Sterling Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.